TRACY KELLEY: Open Payments
NPI 1851943757 · WILMINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,037 in 70 payments from 19 companies in 2025. Trend: 2023 $1,804 · 2024 $3,860 · 2025 $1,037
Food & beverage: $1,037
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC | 16 | $209 |
| ABBVIE INC. | 17 | $194 |
| PFIZER INC. | 11 | $175 |
| Biogen, Inc. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Aucta Pharmaceuticals, Inc. | 4 | $50 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $22 |
Products named: CREXONT, NURTEC ODT, QULIPTA, INGREZZA, KESIMPTA, Motpoly XR, FYCOMPA, VRAYLAR.
Industry payments across OH — which companies pay providers there.
